Submit Deal

Submit Deal

Announced

1 Mar 2019

Completed

18 Mar 2019

Clean Cells completed the acquisition of BE Vaccines from Biological E.

Synopsis

Clean Cells, a CRO specialized in biosafety testing completed the acquisition of BE Vaccines, a French subsidiary of the Indian Pharmaceutical Company Biological E. Financial terms were not disclosed.

Principals

target

Be Vaccines

bidder

Clean Cells

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (11)

Service Providers

Sort

Ugo Audouard

LawyerCounsel at Lamartine Conseil

Frederic Maurel

LawyerAssociate at Mazars Corporate Finance

Marine Cambolin

LawyerAssociate at Mazars Corporate Finance

Sandrine Vouillon

LawyerMazars Corporate Finance

Mathilde Toussaint

LawyerDirector at Mazars Corporate Finance

Sarah Latour

Commercial ConsultantECR Environnement

Benoit Brossard

LawyerAssociate at Oratio Avocats

Olivier Boisteau

ManagerCEO at CLEAN CELLS

Thomas Gross

Commercial ConsultantAssociate Director at Sogedev

Benoit Marpeau

LawyerPartner at Dethomas-Peltier-Juvigny

Guillaume Fornier

LawyerCounsel at Dethomas-Peltier-Juvigny

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.